Avgol (AVGL) AI Stock Analysis

• Market Cap: 439.34M
• Dividend Yield: N/A
• Average Volume (3M): 26.65K
• Price to Earnings (P/E): 101.2
• Beta (1Y): 0.30
• Revenue Growth: 7.20%
• EPS Growth: -65.65%
• Country: IL
• Employees: 915
• Sector: Industrials
• Sector Strength: 84
• Industry: Apparel - Manufacturers
• EPS (TTM): 2.60
• Shares Outstanding: 296,853,100
• 10 Day Avg. Volume: 13,256
• 30 Day Avg. Volume: 26,646
• PEG Ratio: 0.02
• Price to Book (P/B): 0.76
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 7.09
• Enterprise Value/Market Cap: 0.65
• Enterprise Value/Revenue: 0.21
• Enterprise Value/Gross Profit: 5.90
• Enterprise Value/Ebitda: 1.72
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 51 Neutral
• Price Target: 148.00 ▲(2.14%Upside)

The overall stock score for Avgol is weighed down by weak financial performance and a high valuation relative to earnings. Technical analysis provides a slightly better outlook due to neutral RSI and proximity to short-term moving averages. However, the lack of a dividend and high P/E ratio suggest caution for potential investors.

Avgol Business Overview & Revenue Model

Company Description

Avgol (AVGL) is a leading global manufacturer specializing in the production of nonwoven fabrics, primarily for the hygiene, medical, and industrial markets. The company operates several production facilities worldwide, delivering innovative and high-quality materials used in products such as diapers, adult incontinence products, feminine hygiene pads, and various medical applications. Avgol's commitment to technological advancement and sustainability allows it to maintain a strong presence in its sector.

How the Company Makes Money

Avgol makes money by producing and selling nonwoven fabrics to manufacturers who incorporate these materials into end-user products like diapers, sanitary pads, and medical supplies. The company's key revenue streams include long-term supply agreements with major consumer goods companies and healthcare product manufacturers. Additionally, Avgol benefits from strategic partnerships that enhance its global distribution network and technological capabilities. The company's focus on innovation and efficiency in production processes helps maintain competitive pricing and strong customer relationships, contributing to its overall earnings.

Avgol Financial Statement Overview

Summary

Avgol is facing challenges with declining profitability and revenue trends, despite improvements in financial leverage. Negative free cash flow and declining equity could indicate potential liquidity issues.

Income Statement

The income statement shows mixed results. Gross profit margin declined from 24.8% in 2020 to 13.8% in 2024, indicating reduced profitability. Net profit margin turned negative in 2024, highlighting challenges in managing costs or increasing revenues. Revenue growth from 2023 to 2024 was 10.1%, but overall, revenues have been declining since 2020. EBIT and EBITDA margins have also decreased since 2020, reflecting operational inefficiencies.

Balance Sheet

The balance sheet shows moderate financial stability. The debt-to-equity ratio has improved slightly from 1.52 in 2019 to 1.03 in 2024, indicating better leverage management. However, stockholders' equity has decreased since 2019, which could pose a risk if liabilities increase. The equity ratio decreased from 30.9% in 2020 to 40.8% in 2024, suggesting a stable capital structure.

Cash Flow

Cash flow analysis reveals instability in free cash flow, with a negative free cash flow in 2024. Operating cash flow to net income ratio is strong, with operating cash flow consistently positive. However, free cash flow to net income ratio fluctuates, indicating volatility in capital expenditures and cash management.

Breakdown
Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
350.03M	318.07M	426.82M	471.41M	383.02M
	Gross Profit
48.37M	45.36M	76.85M	64.33M	95.06M
	EBIT
18.74M	15.72M	40.49M	27.58M	62.85M
	EBITDA
44.71M	42.35M	72.40M	50.60M	86.46M
	Net Income Common Stockholders
-620.00K	3.99M	27.51M	8.14M	36.76M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
60.89M	50.71M	61.51M	65.94M	75.47M
	Total Assets
469.00M	441.64M	465.68M	489.01M	463.83M
	Total Debt
196.36M	179.96M	187.42M	221.87M	216.72M
	Net Debt
135.47M	130.16M	125.91M	155.92M	141.25M
	Total Liabilities
277.33M	242.63M	255.83M	304.90M	289.04M
	Stockholders Equity
191.39M	198.69M	209.48M	183.65M	174.38M
Cash Flow		Free Cash Flow
-3.64M	-2.87M	22.47M	-17.83M	91.59M
	Operating Cash Flow
42.51M	31.14M	50.70M	25.70M	101.55M
	Investing Cash Flow
-45.89M	-33.42M	-29.92M	-43.15M	-6.02M
	Financing Cash Flow
16.10M	-8.05M	-24.10M	7.59M	-56.81M

Avgol Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 144.90
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:AVGL, the sentiment is Positive. The current price of 144.9 is below the 20-day moving average (MA) of 146.42, below the 50-day MA of 148.04, and above the 200-day MA of 142.70, indicating a neutral trend. The MACD of -0.35 indicates Negative momentum. The RSI at 52.57 is Neutral, neither overbought nor oversold. The STOCH value of 76.34 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IL:AVGL.

Avgol Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
POLI	80 Outperform	$80.36B	10.03	14.26%	3.58%	14.61%	3.90%
ALBA	72 Outperform	362.88M	8.71		―	―	―
Sector *	66 Neutral	$4.44B	12.06	5.34%	6.22%	4.17%	-11.81%
SPEN	61 Neutral	10.09B	52.29		0.79%	4.96%	38.72%
LEVI	56 Neutral	1.82B	46.85		1.51%	―	―
AVGL	51 Neutral	439.34M	101.16		―	7.20%	-65.65%

Avgol Corporate Events

Avgol to Release 2024 Financial Reports and Host Webinar

Avgol has announced the forthcoming release of its financial reports for the fourth quarter and full year of 2024, scheduled for March 6, 2025. The company will host a webinar on March 9, 2025, to discuss these reports, reflecting its commitment to transparency and stakeholder engagement by making the call recording available online. This approach underscores Avgol’s proactive communication strategy and may impact its market perception positively.